Cocaine topical solution - Lannett

Drug Profile

Cocaine topical solution - Lannett

Alternative Names: C-Topical; Cocaine hydrochloride solution - Lannett; Numbrino

Latest Information Update: 18 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lannett
  • Class Alkaloids; Local anaesthetics; Tropanes
  • Mechanism of Action Adrenergic receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Anaesthesia

Most Recent Events

  • 01 Dec 2017 The US FDA accepts NDA filing for cocaine hydrochloride for Anaesthesia in USA (Topical, Solution [4% and 10%])
  • 01 Dec 2017 FDA assigns PDUFA action date of 21/07/2018 for cocaine hydrochloride (4% and 10%) for Anaesthesia (Topical, Solution)
  • 25 Sep 2017 Preregistration for Anaesthesia in USA (Topical, Solution, 10%)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top